Engineering Foot-and-Mouth Disease Viruses with Improved Growth Properties for Vaccine Development

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Zheng, Haixue ^a   Guo, Jianhong ^a   Jin, Ye ^a   Yang, Fan ^a   He, Jijun ^a   Lv, Lv ^a   Zhang, Kesan ^a   Wu, Qiong ^a   Liu, Xiangtao ^a   Cai, Xuepeng ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CATTLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETIC ENGINEERING; HAMSTER; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; VACCINATION; VACCINE PRODUCTION; VIROGENESIS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE ORDER; MICE; PLASMIDS; RNA, VIRAL; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; BOS; CRICETINAE; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 84872836331     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055228     Document Type: Article

References (36)

1. Agol VI, Paul AV, Wimmer E, (1999) Paradoxes of the replication of picornaviral genomes. Virus Res 62: 129-147.
2. Schumann KR, Knowles NJ, Davies PR, Midgley RJ, Valarcher JF, et al. (2008) Genetic characterization and molecular epidemiology of foot-and-mouth disease viruses isolated from Afghanistan in 2003-2005. Virus Genes 36: 401-413.
3. Belsham GJ, (1993) Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol 60: 241-260.
4. Bachrach HL, (1968) Foot-and-mouth disease. Annu Rev Microbiol 22: 201-244.
5. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, et al. (2005) Comparative genomics of foot-and-mouth disease virus. J Virol 79: 6487-6504.
6. Kitching RP, (2005) Global epidemiology and prospects for control of foot-and-mouth disease. Curr Top Microbiol Immunol 288: 133-148.
7. Tosh C, Sanyal A, Hemadri D, Venkataramanan R, (2002) Phylogenetic analysis of serotype A foot-and-mouth disease virus isolated in India between 1977 and 2000. Arch Virol 147: 493-513.
8. Bronsvoort BM, Radford AD, Tanya VN, Nfon C, Kitching RP, et al. (2004) Molecular epidemiology of foot-and-mouth disease viruses in the Adamawa province of Cameroon. J Clin Microbiol 42: 2186-2196.
9. Islam MA, Rahman MM, Adam KH, Marquardt O, (2001) Epidemiological implications of the molecular characterization of foot-and-mouth disease virus isolated between 1996 and 2000 in Bangladesh. Virus Genes 23: 203-210.
10. Klein J, Parlak U, Ozyoruk F, Christensen LS, (2006) The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey. BMC Vet Res 2: 35.
11. Konig GA, Palma EL, Maradei E, Piccone ME, (2007) Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic. Vet Microbiol 124: 1-15.
12. Mattion N, Konig G, Seki C, Smitsaart E, Maradei E, et al. (2004) Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine 22: 4149-4162.
13. Muthuchelvan D, Venkataramanan R, Hemadri D, Sanyal A, Tosh C, (2001) Sequence analysis of recent Indian isolates of foot-and-mouth disease virus serotypes O, A and Asia 1 from clinical materials. Acta Virol 45: 159-167.
14. Tosh C, Hemadri D, Sanyal A, (2002) Evidence of recombination in the capsid-coding region of type A foot-and-mouth disease virus. J Gen Virol 83: 2455-2460.
15. Le VP, Nguyen T, Lee KN, Ko YJ, Lee HS,et al. Molecular characterization of serotype A foot-and-mouth disease viruses circulating in Vietnam in 2009. Vet Microbiol.
16. Knowles NJ, Nazem Shirazi MH, Wadsworth J, Swabey KG, Stirling JM, et al. (2009) Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle East. Transbound Emerg Dis 56: 157-169.
17. Mohapatra JK, Sahu A, Pandey L, Sanyal A, Hemadri D, et al. (2009) Genetic characterization of type A foot-and-mouth disease virus 3A region in context of the reemergence of VP359-deletion lineage in India. Infect Genet Evol 9: 483-492.
18. Blignaut B, Visser N, Theron J, Rieder E, Maree FF, (2011) Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. J Gen Virol 92: 849-859.
19. van Rensburg HG, Henry TM, Mason PW, (2004) Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 85: 61-68.
20. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene 27: 493-497.
21. Quan M, Murphy CM, Zhang Z, Alexandersen S, (2004) Determinants of early foot-and-mouth disease virus dynamics in pigs. J Comp Pathol 131: 294-307.
22. Rodriguez Pulido M, Sobrino F, Borrego B, Saiz M, (2009) Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3′ noncoding region can elicit immunity in swine. J Virol 83: 3475-3485.
23. Guzman E, Taylor G, Charleston B, Ellis SA, (2010) Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination. J Virol 84: 12375-12384.
24. Barnett PV, Keel P, Reid S, Armstrong RM, Statham RJ, et al. (2004) Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. Vaccine 22: 1221-1232.
25. Barnett PV, Cox SJ, Aggarwal N, Gerber H, McCullough KC, (2002) Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. Vaccine 20: 3197-3208.
26. Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, et al. (2005) Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 23: 1106-1113.
27. Cox SJ, Aggarwal N, Statham RJ, Barnett PV, (2003) Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21: 1336-1347.
28. Cox SJ, Barnett PV, Dani P, Salt JS, (1999) Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 17: 1858-1868.
29. Fowler VL, Paton DJ, Rieder E, Barnett PV, (2008) Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle. Vaccine 26: 1982-1989.
30. Rweyemamu MM, Booth JC, Head M, Pay TW, (1978) Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J Hyg (Lond) 81: 107-123.
31. Kitching RP, Rendle R, Ferris NP, (1988) Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Vaccine 6: 403-408.
32. Chang Y, Zheng H, Shang Y, Jin Y, Wang G, et al. (2009) Recovery of infectious foot-and-mouth disease virus from full-length genomic cDNA clones using an RNA polymerase I system. Acta Biochim Biophys Sin (Shanghai) 41: 998-1007.
33. Rieder E, Bunch T, Brown F, Mason PW, (1993) Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol 67: 5139-5145.
34. Lu Z, Cao Y, Guo J, Qi S, Li D, et al. (2007) Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Vet Microbiol 125: 157-169.
35. Shaw AE, Reid SM, Ebert K, Hutchings GH, Ferris NP, et al. (2007) Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. J Virol Methods 143: 81-85.
36. Reid SM, Ferris NP, Hutchings GH, Zhang Z, Belsham GJ, et al. (2002) Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J Virol Methods 105: 67-80.